Your browser doesn't support javascript.
loading
An assessment of quality of life for early phase after adjuvant radiotherapy in breast cancer survivors: a Korean multicenter survey (KROG 14-09).
Rim, Chai Hong; Ahn, Sung-Ja; Kim, Jin Hee; Yoon, Won Sup; Chun, Mison; Yang, Dae Sik; Lee, Jong-Hoon; Kim, Kyubo; Kong, Moonkyoo; Kim, Suzy; Kim, Juree; Park, Kyung Ran; Shin, Young-Joo; Ma, Sun Young; Jeong, Bae-Kwon; Kim, Su Ssan; Kim, Yong Bae; Lee, Dong Soo; Cha, Jaehyung.
Afiliación
  • Rim CH; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Ahn SJ; Department of Radiation Oncology, Chonnam National Univiersity Hwasun Hospital, Hwasun, Jeollanam-do, Republic of Korea.
  • Kim JH; Department of Radiation Oncology, Dongsan Medical Center, Keimyung University, Daegu, Republic of Korea.
  • Yoon WS; Department of Radiation Oncology, Ansan Hospital, Korea University, 123 Jeokgeum-ro, Danwon-gu, Ansan, Gyeonggi-do, 15355, Republic of Korea. irionyws@korea.ac.kr.
  • Chun M; Department of Radiation Oncology, Ajou University, Suwon, Gyeonggi-do, Republic of Korea.
  • Yang DS; Department of Radiation Oncology, Guro Hospital, Korea University, Seoul, Republic of Korea.
  • Lee JH; Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim K; Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kong M; Department of Radiation Oncology, Mokdong Hospital, Ewha Woman's University School of Medicine, Seoul, Republic of Korea.
  • Kim S; Department of Radiation Oncology, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
  • Kim J; Department of Radiation Oncology, Boramae Medical Center, Seoul National University, Seoul, Republic of Korea.
  • Park KR; Department of Radiation Oncology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Republic of Korea.
  • Shin YJ; Department of Radiation Oncology, Mokdong Hospital, Ewha Woman's University School of Medicine, Seoul, Republic of Korea.
  • Ma SY; Department of Radiation Oncology, Sanggye Paik Hospital, Inje University, Seoul, Republic of Korea.
  • Jeong BK; Department of Radiation Oncology, Kosin University Gospel Hospital, Busan, Republic of Korea.
  • Kim SS; Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National Univeristy Hospital, Jinju, Gyeongsangnam-do, Republic of Korea.
  • Kim YB; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Lee DS; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Cha J; Department of Radiation Oncology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Uijeongbu, Gyeonggi-do, Republic of Korea.
Health Qual Life Outcomes ; 15(1): 96, 2017 May 10.
Article en En | MEDLINE | ID: mdl-28486990
ABSTRACT
BACKGROUNDS Quality of life (QoL) has become a major concern as the survival time of breast cancer increases. We investigated the changes in QoL through comprehensive categorical analysis, for the first three years after breast cancer treatment including radiotherapy.

METHODS:

A total of 1156 patients were enrolled from 17 institutions. All survivors were grouped according to a surveillance period of 9-15 months (first year), 21-27 months (second year), and 33-39 months (third year) from the end of radiotherapy. The 5-dimensional questionnaire by the EuroQol group (EQ-5D) and the EORTC Quality of Life Questionnaire; breast cancer specific module (QLQ-BR23) were checked by self-administrated method.

RESULTS:

First, second and third year groups comprised 51.0, 28.9, and 21.0%. In EQ-5D-3 L (3-Likert scale) analysis, pain/discomfort and anxiety/depression categories showed lower QoL. In multivariate analyses of EQ-5D-VAS (visual-analogue scale), categories of pain/discomfort and self-care were improved with time; axillary dissection was a significant clinical factor deteriorates pain/discomfort, self-care and usual activities. In QLQ-BR23 analysis, the lowest scored category was sexual activity, followed by sexual enjoyment, future perspective, and hair loss, and the best scored category was breast symptoms. In multivariate analyses, arm symptoms, breast symptoms and body image were improved with time.

CONCLUSIONS:

Categories of pain/discomfort and self-care in EQ-5D-VAS, arm/breast symptoms and body image in QLQ-BR23 were improved, while categories of anxiety/depression and future perspective BR23 were not, suggesting necessity of psychosocial support. This research provides comprehensive information on the categorical aspects of QoL and changes during early follow-up after breast cancer treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama / Sobrevivientes / Radioterapia Adyuvante Tipo de estudio: Clinical_trials / Qualitative_research Aspecto: Patient_preference Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Health Qual Life Outcomes Asunto de la revista: SAUDE PUBLICA Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama / Sobrevivientes / Radioterapia Adyuvante Tipo de estudio: Clinical_trials / Qualitative_research Aspecto: Patient_preference Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Health Qual Life Outcomes Asunto de la revista: SAUDE PUBLICA Año: 2017 Tipo del documento: Article